Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the site; the available changes point to a backend or UI update rather than a modification of study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:05.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.5 to v3.6.6, signaling an updated build of the ClinicalTrials.gov page. This maintenance update does not change the study information displayed.
    Difference
    0.1%
    Check dated 2026-09-01T18:12:22.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.4 to v3.6.5, indicating a site update. The study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-11T14:43:18.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updated study timeline dates: primary completion now 2026-12-30 and study completion now 2027-06-28. A new Revision: v3.6.4 tag appears, indicating an updated page version.
    Difference
    0.3%
    Check dated 2026-07-28T05:33:44.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page. This change typically reflects maintenance updates and does not alter the study data or eligibility details.
    Difference
    0.0%
    Check dated 2026-07-06T16:46:08.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision line now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a newer version of the page has been published.
    Difference
    0.0%
    Check dated 2026-06-29T08:50:41.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.